Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
AstraZeneca
Baxter
Queensland Health
Cerilliant
US Department of Justice
UBS
US Army

Generated: January 18, 2019

DrugPatentWatch Database Preview

Eculizumab - Biologic Drug Details

« Back to Dashboard

Summary for eculizumab
Tradenames:1
Patents:60
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for eculizumab
Pharmacology for eculizumab
Mechanism of ActionComplement Inhibitors

US Patents for eculizumab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Alexion Pharmaceuticals, Inc. (Cheshire, CT) ➤ Sign Up RX Orphan company
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Janssen Pharmaceutica NV (Beerse, BE) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up ForSight Vision4, Inc. (Menlo Park, CA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for eculizumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0016 France ➤ Sign Up PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
C/GB10/015 United Kingdom ➤ Sign Up PRODUCT NAME: ECULIZUMAB; REGISTERED: UK EU/1/07/393/001 20070620
2010 00003 Denmark ➤ Sign Up
12/2010 Austria ➤ Sign Up PRODUCT NAME: ECULIZUMAB
C002/2010 Ireland ➤ Sign Up SPC002/2010: 20100902, EXPIRES: 20200430
00433 Netherlands ➤ Sign Up PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Citi
Cerilliant
Queensland Health
Federal Trade Commission
Fish and Richardson
Moodys
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.